Risk score = LncRNAs associated with doxorubicin metabolism can be used as molecular markers for immune microenvironment and immunotherapy in non-small cell lung cancer
Author:
Publisher
Elsevier BV
Subject
Multidisciplinary
Reference31 articles.
1. Resveratrol protects against acute chemotherapy toxicity induced by doxorubucin in rat erythrocyte and plasma;Hamlaoui;J. Physiol. Pharmacol.,2012
2. Self-targeted polymersomal co-formulation of doxorubicin, camptothecin and FOXM1 aptamer for efficient treatment of non-small cell lung cancer;Shahriari;J. Contr. Release,2021
3. Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via maintaining AMPKalpha/UCP2 pathway;Hu;Acta Pharm. Sin. B,2019
4. Molecular pathways: coexpression of immune checkpoint molecules: signaling pathways and implications for cancer immunotherapy;Nirschl;Clin. Cancer Res.,2013
5. Elimination of established tumors with nanodisc-based combination chemoimmunotherapy;Kuai;Sci. Adv.,2018
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A ferroptosis‐related LncRNAs signature for predicting prognoses and screening potential therapeutic drugs in patients with lung adenocarcinoma: A retrospective study;Cancer Reports;2023-12-03
2. Computational identification of long non-coding RNAs associated with graphene therapy in glioblastoma multiforme;Brain Communications;2023-10-25
3. Comprehensive assessment of base excision repair (BER)-related lncRNAs as prognostic and functional biomarkers in lung adenocarcinoma: implications for personalized therapeutics and immunomodulation;Journal of Cancer Research and Clinical Oncology;2023-10-03
4. Editorial: Epigenetics in cancer: mechanisms and drug development-volume II;Frontiers in Genetics;2023-07-05
5. A lncRNA-disease association prediction model based on the two-step PU learning and fully connected neural networks;Heliyon;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3